Danish health authorities said on Monday they would ask the European Union’s drug regulator to review the findings of two Danish studies linking Novo Nordisk’s popular diabetes drug Ozempic to a rare sight-threatening eye condition.
Orly Vardeny, PharmD, MS explores the efficacy of nonsteroidal MRAs in heart failure with mildly reduced or preserved ejection fraction in the FINE-ARTS trial.
Dedicated to the understanding and advancement of sciences our Physical Sciences portfolio features extensive and diverse resources.
The reforms are part of a government funding package set to be passed this year.
The study found changes to proteins in the blood—at 57, 70, and 78 years of age—marked three distinct phases of brain aging.
The reforms are part of a government funding package set to be passed this year.
The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson’s drug Rybrevant for a type of lung cancer,…
The mega iceberg is twice the size of Greater London.
President-elect Donald Trump said he plans to “knock out” drug-industry middlemen, a sign the sector isn’t likely to see relief from political scrutiny.
It may employ a kind of reasoning humans use all the time — but you’ve probably never heard of it.
Despite marketing claims, none of six dietary supplements commonly used for lipid lowering significantly reduced LDL cholesterol versus placebo adults with elevated atherosclerotic risk, a…
